Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sato Vicki L
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   1,672,571    

Indirect Shares

   8,084      
Direct Value   $36,205,289    

Indirect Value

   $3,213,228      
Total Shares   1,680,655      
Total Value   $39,418,517      


Vertex Pharmaceuticals Inc $30,698,573 Perkinelmer Inc $3,042,255 Infinity Pharmaceuticals Inc $0 Borgwarner Inc $643,058 Denali Therapeutics Inc. $1,821,403 Vir Biotechnology, Inc. $0 Allogene Therapeutics, Inc. $0 Vertex Pharmaceuticals Inc $30,698,573 Perkinelmer Inc $3,042,255 Infinity Pharmaceuticals Inc $0 Borgwarner Inc $643,058 Denali Therapeutics Inc. $1,821,403 Vir Biotechnology, Inc. $0 Allogene Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX President 2005-05-11 77,233 2005-05-11 8,084    Premium*  
            Perkinelmer Inc PKI Director 2017-02-09 29,970 2004-04-27 0    Premium*  
            Infinity Pharmaceuticals Inc INFI Director 2006-09-12 11,051 2006-09-12 0    Premium*  
            Borgwarner Inc BWA Director 2020-04-29 19,823 2014-04-30 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-04-15 118,043 2017-12-12 0    Premium*  
            Vir Biotechnology, Inc. VIR Director 2023-06-30 1,315,351 0    Premium*  
            Allogene Therapeutics, Inc. ALLO 2023-06-13 101,100 2021-07-30 0    Premium*  
* Premium Members only  

Records found :    226         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 10
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VIR Vir Biotechnology, Inc. Director   –       •      –    2019-10-10 3 IO $0.00 $0 D/D 0 1,669,110 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-10-20 4 OE $9.50 $5,605 D/D 590 108,698 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-10-20 4 AS $10.50 $6,195 D/D (590) 108,108 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-03-03 4 AS $60.36 $102,641 D/D (1,666) 139,087 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-03-31 4 AS $54.38 $93,992 D/D (1,666) 137,421 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-04-28 4 AS $60.71 $103,538 D/D (1,666) 135,755 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-05-26 4 AS $64.90 $108,911 D/D (1,666) 134,089 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-06-23 4 AS $70.20 $117,845 D/D (1,666) 134,497 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-07-21 4 AS $64.25 $108,510 D/D (1,666) 132,831 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-08-18 4 AS $51.26 $86,139 D/D (1,666) 131,165 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-09-15 4 AS $52.28 $88,969 D/D (1,666) 129,499 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-11-01 4 AS $50.05 $83,383 D/D (1,666) 127,833 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-11-10 4 AS $52.49 $87,983 D/D (1,666) 126,167 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-06-28 4 AS $29.55 $49,709 D/D (1,666) 134,703 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-07-17 4 AS $29.60 $49,314 D/D (1,666) 133,037 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-08-15 4 AS $24.30 $40,484 D/D (1,666) 131,371 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-09-15 4 AS $23.60 $39,348 D/D (1,666) 129,705 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-10-16 4 AS $20.66 $34,420 D/D (1,666) 128,039 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-11-15 4 AS $19.13 $31,871 D/D (1,666) 126,373 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-12-15 4 AS $23.39 $38,968 D/D (1,666) 124,707 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-01-16 4 AS $18.42 $30,688 D/D (1,666) 123,041 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-02-15 4 AS $18.37 $30,604 D/D (1,666) 121,375 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-03-15 4 AS $20.10 $33,487 D/D (1,666) 119,709 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-04-15 4 AS $18.29 $30,471 D/D (1,666) 118,043 0 %
BWA Borgwarner Inc Director   •       •      –    2014-04-30 4 A $61.40 $114,993 D/D 1,873 1,873 0 -
  226  Records found
  1  2   3   4   5   6   7   8   9   10      
  Page 1 of 10  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us